PBH vs SPB

For growth investors, Prestige Consumer Healthcare Inc.

(PBH) is the stronger pick with 1. 1% revenue growth year-over-year, versus -5. 2% for Spectrum Brands Holdings, Inc. (SPB). Prestige Consumer Healthcare Inc. (PBH) offers the better valuation at 12. 7x trailing P/E (12. 0x forward), making it the more compelling value choice. Analysts rate Prestige Consumer Healthcare Inc. (PBH) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Prestige Consumer Healthcare Inc.

(PBH) is the cheapest at 12. 7x versus Spectrum Brands Holdings, Inc. at 22. 0x. On forward P/E, Prestige Consumer Healthcare Inc. is actually cheaper at 12. 0x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Spectrum Brands Holdings, Inc. wins at 1. 24x versus Prestige Consumer Healthcare Inc. 's 1. 32x — a reasonable growth-adjusted valuation.

Over the past 5 years, Prestige Consumer Healthcare Inc.

(PBH) delivered a total return of +15. 3%, compared to +2. 4% for Spectrum Brands Holdings, Inc. (SPB). Over 10 years, the gap is even starker: SPB returned +13. 5% versus PBH's -3. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Prestige Consumer Healthcare Inc.

(PBH) is the lower-risk stock at 0. 53β versus Spectrum Brands Holdings, Inc. 's 0. 82β — meaning SPB is approximately 53% more volatile than PBH relative to the S&P 500. On balance sheet safety, Spectrum Brands Holdings, Inc. (SPB) carries a lower debt/equity ratio of 34% versus 57% for Prestige Consumer Healthcare Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Prestige Consumer Healthcare Inc.

(PBH) is pulling ahead at 1. 1% versus -5. 2% for Spectrum Brands Holdings, Inc. (SPB). On earnings-per-share growth, the picture is similar: Prestige Consumer Healthcare Inc. grew EPS 2. 9% year-over-year, compared to -5. 6% for Spectrum Brands Holdings, Inc.. Over a 3-year CAGR, PBH leads at 1. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Prestige Consumer Healthcare Inc.

(PBH) is the more profitable company, earning 18. 9% net margin versus 3. 6% for Spectrum Brands Holdings, Inc. — meaning it keeps 18. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PBH leads at 29. 6% versus 4. 4% for SPB. At the gross margin level — before operating expenses — PBH leads at 55. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Spectrum Brands Holdings, Inc. (SPB) is the more undervalued stock at a PEG of 1. 24x versus Prestige Consumer Healthcare Inc. 's 1. 32x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Prestige Consumer Healthcare Inc. (PBH) trades at 12. 0x forward P/E versus 16. 1x for Spectrum Brands Holdings, Inc. — 4. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PBH: 21. 5% to $66. 00.

In this comparison, SPB (2.

2% yield) pays a dividend. PBH does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Spectrum Brands Holdings, Inc.

(SPB) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 82), 2. 2% yield). Both have compounded well over 10 years (SPB: +13. 5%, PBH: -3. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (PBH (Healthcare) and SPB (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: PBH is a small-cap deep-value stock; SPB is a small-cap quality compounder stock. SPB pays a dividend while PBH does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.